ICD-10 code for alcohol abuse with alcohol-induced psychotic disorder, with hallucinations

F10.151 is the ICD-10 code for alcohol abuse with alcohol-induced psychotic disorder, with hallucinations.

This diagnosis indicates a pattern of problematic alcohol use that has reached abuse-level severity accompanied by psychotic symptoms that include auditory or visual hallucinations directly caused by alcohol consumption.

Accurate diagnosis and documentation ensures appropriate treatment while supporting insurance reimbursement for necessary clinical interventions.

Key features:

• F10.151 ICD-10 code represents alcohol abuse severity (2-3 DSM-5 criteria) with psychotic complications
• Hallucinations occur as a direct result of chronic alcohol use, typically auditory or visual
• Requires differential diagnosis from alcohol withdrawal delirium and primary psychotic disorders
• Treatment combines antipsychotic medication with comprehensive substance abuse interventions

Diagnostic criteria for alcohol abuse with alcohol-induced psychotic disorder (F10.151)

Clinicians must establish two distinct but related conditions to assign F10.151. The alcohol abuse component requires meeting at least two but fewer than four DSM-5 criteria within a 12-month period.

These criteria encompass impaired control over drinking, social impairment, risky use patterns, and evidence of tolerance or withdrawal symptoms.

The psychotic disorder component involves hallucinatory experiences directly attributable to chronic alcohol consumption.

Unlike alcohol withdrawal delirium, individuals with alcohol-related hallucinosis maintain a clear sensorium and normal cognitive functioning.

The hallucinations typically manifest as auditory phenomena, though visual hallucinations can occur.

These symptoms may emerge during active drinking or persist into withdrawal periods.

The diagnosis requires establishing temporal relationships between alcohol use patterns and psychotic symptom onset.

Clinicians must rule out pre-existing psychotic disorders and other medical conditions that could produce similar presentations.

The hallucinations must be sufficiently distressing or functionally impairing to warrant clinical attention beyond basic alcohol abuse treatment.

When to use F10.151 diagnosis code

Proper application of F10.151 requires careful consideration of symptom severity, temporal patterns, and differential diagnoses.

This code specifically applies when alcohol use meets abuse-level criteria while psychotic symptoms include hallucinatory experiences.

F10.151 vs F10.150 (Alcohol abuse with alcohol-induced psychotic disorder, with delusions)

F10.151 applies when hallucinations represent the primary or exclusive psychotic symptom, while F10.150 is used when delusions predominate.

Some individuals may experience both phenomena, requiring clinical judgment about which symptoms are more prominent or functionally impairing.

Persecutory delusions commonly accompany alcohol-related hallucinosis, but F10.151 remains appropriate when hallucinations are the presenting concern.

F10.151 vs F10.159 (Alcohol abuse with alcohol-induced psychotic disorder, unspecified)

F10.159 applies when psychotic symptoms are present but their specific nature remains unclear or when mixed presentations make it difficult to classify symptoms as primarily hallucinatory or delusional.

F10.151 should be used when hallucinations can be clearly identified and documented as the predominant psychotic feature.

F10.151 vs F10.251 (Alcohol dependence with alcohol-induced psychotic disorder, with hallucinations)

The distinction between these codes rests entirely on alcohol use severity.

F10.151 applies when only 2-3 DSM-5 criteria are met (abuse level), while F10.251 is used when 4 or more criteria are present (dependence level).

The psychotic component remains identical between these diagnoses.

Related ICD-10 codes

• F10.15 - Alcohol abuse with alcohol-induced psychotic disorder (parent code)
• F10.150 - Alcohol abuse with alcohol-induced psychotic disorder, with delusions
• F10.159 - Alcohol abuse with alcohol-induced psychotic disorder, unspecified

Interventions and CPT codes for alcohol abuse with alcohol-induced psychotic disorder

Treatment for F10.151 requires integrated approaches addressing both substance abuse and psychotic symptoms.

Evidence-based interventions target alcohol reduction while managing distressing hallucinatory experiences through both pharmacological and psychosocial methods.

Psychiatric evaluation and medication management

Comprehensive psychiatric evaluation establishes the diagnosis and guides treatment planning.

Initial assessment should use CPT 90791 for psychiatric diagnostic evaluation, particularly valuable during first visits when determining the relationship between alcohol use patterns and psychotic symptoms.

Medication management visits using CPT 99213-99215 (established patient office visits) support ongoing antipsychotic medication monitoring.

Antipsychotic medications effectively reduce hallucination severity and associated distress, with haloperidol, olanzapine, and risperidone representing common choices.

These medications should never be used alone but always combined with adequate alcohol withdrawal management when needed.

Individual psychotherapy

Psychotherapy sessions target both alcohol abuse patterns and psychotic symptom management.

CPT 90832 (30-minute sessions), 90834 (45-minute sessions), or 90837 (60-minute sessions) support individual therapy using motivational interviewing, cognitive-behavioral approaches, and relapse prevention strategies.

Therapy sessions often focus on helping clients understand connections between alcohol use and psychotic symptoms while developing coping strategies for managing hallucinatory experiences.

Sessions may also address medication adherence and lifestyle changes supporting long-term recovery.

Screening and brief intervention (SBIRT)

Structured screening and brief intervention services help assess alcohol use severity and provide focused counseling.

CPT 99408 covers 15-30 minute screening and intervention sessions, while 99409 applies to sessions exceeding 30 minutes. These codes are particularly useful in emergency or medical settings where F10.151 patients may first present.

Medicare patients may qualify for G0396 (15-30 minutes) or G0397 (over 30 minutes) for structured assessment and brief intervention services. Some Medicaid programs use H0049 for alcohol screening and H0050 for brief intervention services.

Group therapy and family involvement

Group psychotherapy (CPT 90853) provides peer support while addressing both substance use and mental health concerns.

Groups specifically designed for dual diagnosis clients offer particular value for individuals managing both alcohol abuse and psychotic symptoms.

Family therapy sessions using CPT 90846 (without patient) or 90847 (with patient) address family dynamics, support system development, and relapse prevention planning.

Family members often require education about alcohol-induced psychotic disorders and their role in supporting recovery.

How Upheal improves F10.151 ICD-10 documentation

Clinical documentation for complex dual diagnoses like F10.151 requires precise attention to both substance abuse patterns and psychotic symptom presentations.

Upheal's clinical documentation platform helps streamline this challenging documentation process.

Suggesting appropriate ICD-10 codes based on session content

Upheal analyzes session discussions about alcohol use patterns, hallucination experiences, and functional impairment levels to suggest appropriate diagnostic codes.

The platform recognizes key phrases and symptom descriptions that differentiate F10.151 from related alcohol-induced disorders, reducing coding errors that could affect reimbursement or treatment authorization.

The system helps clinicians distinguish between alcohol abuse and dependence severity levels while accurately capturing psychotic symptom presentations.

This support proves particularly valuable when managing clients with complex presentations involving both substance use and mental health symptoms.

Maintaining HIPAA-compliant records with proper diagnostic coding

Documentation for F10.151 requires careful attention to both alcohol use history and psychotic symptom details while maintaining full HIPAA compliance.

Upheal ensures all clinical records meet privacy requirements while capturing the detailed information needed for accurate diagnosis and treatment planning.

The platform automatically generates progress notes that document symptom severity, medication responses, and treatment plan modifications.

This comprehensive documentation supports insurance requirements while providing the clinical detail needed for ongoing care coordination.

Reducing administrative burden so you can focus on client care

Managing clients with dual diagnosis conditions like F10.151 requires significant clinical attention and complex treatment coordination.

Upheal reduces documentation time by automatically generating detailed progress notes that capture both substance abuse treatment progress and psychotic symptom management.

The platform helps clinicians track medication adherence, symptom fluctuations, and treatment response patterns without extensive manual note-taking.

This efficiency allows more time for direct client care while ensuring comprehensive documentation that supports treatment authorization and reimbursement.

Supporting clients with alcohol abuse and alcohol-induced psychotic disorder

Individuals experiencing F10.151 face the complex challenge of managing both substance abuse patterns and distressing psychotic symptoms.

The hallucinatory experiences often feel frightening and real, creating additional barriers to alcohol reduction efforts.

Treatment success requires patience and comprehensive support addressing both conditions simultaneously.

Clients benefit from psychoeducation about the relationship between alcohol use and psychotic symptoms, as many individuals don't initially recognize this connection.

The prognosis for alcohol-related hallucinosis is generally positive when long-term abstinence can be achieved and maintained.

However, some individuals may develop chronic psychotic symptoms requiring ongoing psychiatric care. Early intervention and integrated treatment approaches improve outcomes significantly.

Clinicians can improve their F10.151 documentation accuracy and efficiency by exploring Upheal's clinical documentation platform.

Try Upheal today to experience how intelligent documentation tools can support your complex dual diagnosis cases while reducing administrative burden.